PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.\', \'Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.\', \'Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.\', \'Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA.\', \'Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/jnci/djaa162
?:doi
?:hasPublicationType
?:journal
  • Journal of the National Cancer Institute
is ?:pmid of
?:pmid
?:pmid
  • 33057660
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.488
?:rankingScore_hIndex
  • 326
?:title
  • COVID-19, Social Justice, and Clinical Cancer Research.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all